PEAK6 Investments’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,653
Closed -$106K 3737
2024
Q2
$106K Buy
+3,653
New +$108K ﹤0.01% 3012
2024
Q1
Sell
-2,224
Closed -$96.9K 4319
2023
Q4
$96.9K Buy
+2,224
New +$87.5K ﹤0.01% 3558
2021
Q2
Sell
-6,668
Closed -$461K 5396
2021
Q1
$461K Sell
6,668
-13,746
-67% -$931K ﹤0.01% 3293
2020
Q4
$1.32M Buy
20,414
+13,437
+193% +$723K ﹤0.01% 2215
2020
Q3
$329K Sell
6,977
-2,599
-27% -$124K ﹤0.01% 3156
2020
Q2
$450K Buy
+9,576
New +$471K ﹤0.01% 2770
2019
Q4
Sell
-10,186
Closed -$612K 3688
2019
Q3
$612K Sell
10,186
-3,636
-26% -$217K ﹤0.01% 2120
2019
Q2
$772K Buy
13,822
+3,724
+37% +$192K 0.01% 1970
2019
Q1
$563K Buy
10,098
+7,717
+324% +$393K ﹤0.01% 2295
2018
Q4
$107K Sell
2,381
-60,709
-96% -$3.33M ﹤0.01% 3367
2018
Q3
$4.16M Buy
+63,090
New +$3.92M 0.02% 897

Other funds holding IART

PEAK6 Investments's IART Position: Q3 2024 in Review

PEAK6 Investments sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 3,653 shares — an estimated $106K sold.

PEAK6 Investments first reported a position in IART in Q3 2018 and held it in 11 quarters. The position peaked at $4.16M in Q3 2018. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

  • PEAK6 Investments reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 3,653 Integra LifeSciences shares in Q3 2024, an estimated $106K.
  • PEAK6 Investments first reported a position in Integra LifeSciences in Q3 2018 and held it in 11 quarters.
  • PEAK6 Investments's Integra LifeSciences position peaked at $4.16M in Q3 2018.
  • 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.